Tumor News and Research

RSS

UGA researchers create carbohydrate-based cancer vaccine

When cells become cancerous, the sugars on their surfaces undergo distinct changes that set them apart from healthy cells.

29 Oct 2007

Which lung volumes to use for radiotherapy planning of lung cancer

A new method to standardize the reporting of radiation dose volumes in the use of four-dimensional computed tomography (4D-CT) can lead to a more accurate radiation dose to the lungs in lung cancers, thereby lowering the risk of lung injury, according to a study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

Research clarifies origin of mammalian network of lymphatic vessels

Investigators at St. Jude Children's Research Hospital settled a century-old debate on the origin of the mammalian lymphatic vasculature - the network of vessels and capillaries critical to various essential housekeeping functions in the body.

29 Oct 2007

Nventa Biopharmaceuticals receives new U.S. patent

Nventa Biopharmaceuticals Corporation has announced that the U.S. Patent and Trademark Office has issued Patent Number 7,262,014 to Nventa covering compositions and methods for inducing or enhancing immune responses to a human papillomavirus (HPV) antigen with or without the use of an adjuvant.

29 Oct 2007

New treatment option studied for bladder cancer

A chemotherapy regimen for patients with advanced bladder cancer who aren't eligible for standard treatment is under study at the Medical College of Georgia.

29 Oct 2007

Higher radiation doses over shorter periods of time for prostate cancer doesn't lead to sexual dysfunction

Recent advances in the delivery of radiation therapy for prostate cancer are fueling a new trend of providing higher radiation doses over shorter periods of time.

29 Oct 2007

Extra radiation dose prevents breast cancer return in young women

Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation (boost dose) after undergoing breast-conserving surgery (lumpectomy) and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose, according to a large European study presented at the Plenary I session on October 29, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

29 Oct 2007

Women with breast cancer have less dermatitis when treated with intensity-modulated radiation therapy

All women treated with radiation therapy for breast cancer are at risk of developing dermatitis - a sometimes-painful skin condition caused by radiation as it makes its way through the skin to the tumor area and tissue within the breast.

28 Oct 2007

Walking prevents bone loss caused from prostate cancer treatment

Exercise may reduce, and even reverse, bone loss caused by hormone and radiation therapies used in the treatment of localized prostate cancer, thereby decreasing the potential risk of bone fractures and improving quality of life for these men, according to a study presented on October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

28 Oct 2007

Smoking does not result in more advanced stage diagnoses or aggressive breast cancers

Smoking cigarettes is associated with an increased risk of cancers of the lung, head and neck, esophagus, bladder and many others and also affects response to anti-cancer treatments.

28 Oct 2007

Possible biomarker for colon cancer in people under 50

An abnormality of chromosomes long associated with diseases of aging has, for the first time, been linked to colon cancer in people 50 years old and younger, an age group usually considered young for this disease.

28 Oct 2007

Positioning pelvic cancer patients on stomachs for radiation yields better results

Oregon Health & Science University Cancer Institute researchers have found that positioning pelvic cancer patients on their stomachs rather than their backs is a better method for delivering radiation therapy.

28 Oct 2007

PET scans track small tumors after stereotactic body radiotherapy

Readily available CT screening for lung cancer is increasing the discovery of small, primary lung cancers.

28 Oct 2007

Advancement in radiation oncology treatment called IMRT improves care, avoids healthy tissue

New advancements in a radiation oncology treatment called IMRT (intensity modulated radiation therapy) are proving far superior to standard radiation procedures used today in safeguarding the healthy tissues surrounding cancerous tumors, and thus improving patient care.

28 Oct 2007

Possible biomarker for colon cancer in people 50 and under

28 Oct 2007

Highly targeted radiation therapy for prostate cancer prevents damage to surrounding organs

Oregon Health & Science University Cancer Institute researchers have found that highly targeted radiation therapy for prostate cancer can ensure that the majority of persons with this tumor will not have any long-term rectal damage.

28 Oct 2007

Discovery of a key cell-signaling pathway

University of Alabama at Birmingham (UAB) researchers have discovered a key cell-signaling pathway that regulates cell progression and switches on front-to-back body patterning in tadpoles.

28 Oct 2007

Emerging cancer therapies and novel targets

What are the cancer drugs of tomorrow and how will they be developed? At the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, researchers will present some answers to these and other pressing questions regarding emerging cancer therapeutics.

25 Oct 2007

Blood markers can help choose best dose for antiangiogenic drugs

Scientists at Sunnybrook have new information that may help to improve the use of anti-cancer drugs designed to block the growth of new blood vessels in tumors, a process called angiogenesis that is critical to tumor growth.

25 Oct 2007

Medical College of Wisconsin receives grant to study infantile hemangiomas

The Food and Drug Administration (FDA) has awarded the Medical College of Wisconsin in Milwaukee a three-year, $1 million Orphan Products Development grant to study infantile hemangiomas – a vascular tumor of the skin or internal organs.

25 Oct 2007